H1N1 vaccine trial begins
—
filed under:
News
Vanderbilt's Vaccine and Treatment Evaluation Unit (VTEU) is one of a nationwide network of vaccine units funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Click here to read the full article:http://www.mc.vanderbilt.edu/reporter/index.html?ID=7471


Previous:
From Health to Hope: A week in Mozambique with Vanderbilt's Friends in Global Health
